EGF and breast cancer: These facts, together with the identification of TGFβ1, IGF1 and EGF as potential upstream regulators of our 30 target genes, highlights the relevance of the molecular network centered on β-catenin for chemoresitance in breast cancer and its connections with the EMT process and CSCs biology, a hypothesis that warrants further investigation.